1. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Komelith P, Smith BH, Patronas NJ, Kufia CV, Kessler R, Johnston G, Manning RG, Wolf A: Glucose Utilization of cerebral gliomas measurement by (18F) fluorodeoxyglucose and positron emission tomography Neurology 32: 1323?1329, 1982
2. Alavi JB, Alava A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074?1078, 1988
3. DeLa Paz RLm Patronas NJ, Brooks RA, Smith BH, Kornblith PL, Millam H, DiChiro G: Positron emission tomographic study of suppression of gray-glucose utilization by brain tumors. AHNR 4: 826?829, 1983
4. Alavi JB, Alavi A, Powe J, Hackney D, Reivich M: Metabolic & structural findings related to white matter disorders as shown by PET, MRI, and CT. J Nuclear Med 27: 889, 1986
5. Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, Alavi J, Reivich M: Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. J Nucl Med 28: 1667?1670, 1987